Stephen Kanovsky's most recent trade in Neogenomics Inc. was a trade of 23,077 Restricted Stock Unit done . Disclosure was reported to the exchange on June 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 23,077 | 23,077 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 16,107 | 16,107 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 12,254 | 52,344 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 12,254 | 0 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Purchase of securities on an exchange or from another person at price $ 7.78 per share. | 07 May 2025 | 4,000 | 40,090 (0%) | 0% | 7.8 | 31,124 | Common Stock |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 0 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 36,090 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 12,254 | 12,254 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Stephen M. Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 8,672 | 8,672 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Stephen Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 11,336 | 11,336 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Stephen Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 8,353 | 8,353 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Stephen Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,556 | 24,754 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Stephen Kanovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 13,882 | 13,882 | - | - | Stock Options (Right to Buy) |